|
|
|
| home > epc > winter 2002 > meeting new pharmacovigilance challenges - the need for outsourcing |
|
|
 PUBLICATIONS |
European Pharmaceutical Contractor
|
Until recently the idea of outsourcing pharmacovigilance activities fell outside the comfort zone of all but a few pharmaceutical companies. This was in the main due to fear of the legal ramifications if the outsourcing partner 'got it wrong', and a reluctance to be the first to adopt the outsourcing model. It was also a reflection of the limited choice of both service providers and scope of services available at the time. In 1997 one of the authors, while working for a virtual development company, systematically examined the provision of such services and could identify only a few companies capable of meeting fully outsourced pharmacovigilance requirements.
In contrast, today's marketplace offers a wide range of pharmacovigilance services provided by both large and small companies. These may form part of a suite of services offered by CROs, be the core business of specialist companies, or form part of the expertise available through the growing network of freelance individuals, many of whom are former pharmaceutical company employees.
This growth in the services available for pharmacovigilance outsourcing has been driven by the annual increase in the volume of data generated both in terms of number of individual adverse event case reports and contributing organisations. This has prompted both the regulatory authorities and the pharmaceutical industry to seek more efficient methods of processing product adverse event data with the goal of both improving public safety and reducing the cost overhead for marketing and support of pharmaceutical products in the European Community and beyond.
|
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
2012 BIO International Convention
18-21 June 2012, Boston, Massachusetts
Connect, partner and innovate at the 2012 BIO International Convention, June 18-21, Boston, Mass. Network with 15,000+ global biotech leaders in the BIO Business Forum, Exhibition and Programme.
More info >> |
|
 |
News and Press Releases |
 |
Pantec Biosolutions to Present P.L.E.A.S.E.® Professional for Transdermal Drug Delivery at DDP in Las Vegas
Pantec Biosolutions AG, the developer and manufacturer of P.L.E.A.S.E.® Professional, a state of the art portable laser device that sets new standards for safety, precision and versatility, today announced that it will be giving a scientific company presentation during the “Drug Delivery Partnerships” conference from 25th -27th January 2012 in Las Vegas, USA.
More info >> |
|
|
